1 Min Read
* COMBIGENE AND CELL AND GENE THERAPY CATAPULT SIGN AGREEMENT TO DEVELOP MANUFACTURING PROCESS FOR NOVEL GENE THERAPY TO TREAT EPILEPSY Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.